Market Tracker

09/03 6:36am ET

Novogen Ltd (NASDAQ:NVGN)

2.41
Delayed Data
As of Sep 02
 +0.0153 / +0.64%
Today’s Change
1.51
Today|||52-Week Range
9.50
+15.64%
Year-to-Date

Today’s Trading

Previous close2.39
Today’s open2.43
Day’s range2.34 - 2.47
Volume48,692
Average volume (3 months)212,498
Market cap$16.1M
Dividend yield--
Data as of 09/02/2015

Growth & Valuation

Earnings growth (last year)+18.03%
Earnings growth (this year)--
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book13.31

Competitors

 Today’s
change
Today’s
% change
ECTEEcho Therapeutics In...-0.03-2.00%
DARADARA BioSciences Inc-0.01-1.19%
CDXICardax Inc0.000.00%
CAPNCapnia Inc0.000.00%
Data as of 09/02/2015

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$6.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Iain Gladstone Ross
COO, Head-Administration &
Finance
Cristyn Humphreys
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts